SANIONA AB (PUBL) Net Assets
SANIONA AB (PUBL) net assets. Based on the latest financial reports, SANIONA AB (PUBL) (30S) has net assets worth €635.16 Million EUR (≈ $742.57 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€679.74 Million ≈ $794.69 Million USD) and total liabilities (€44.58 Million ≈ $52.12 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore net asset momentum of SANIONA AB (PUBL) to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €635.16 Million |
| % of Total Assets | 93.44% |
| Annual Growth Rate | 22.51% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 136.8 |
Net Assets of SANIONA AB (PUBL) (2021–2025)
Net assets of SANIONA AB (PUBL) from 2021 to 2025. This chart illustrates how SANIONA AB (PUBL)'s net assets have evolved over time, based on quarterly financial data. See 30S equity to assets ratio to measure how much of total assets are equity-financed.
Annual Net Assets for SANIONA AB (PUBL) (2021–2025)
The table below shows the annual net assets of SANIONA AB (PUBL) from 2021 to 2025. For live market cap and overall valuation, see SANIONA AB (PUBL) (30S) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €635.16 Million ≈ $742.57 Million |
+173.99% |
| 2024-12-31 | €231.82 Million ≈ $271.02 Million |
+1156.60% |
| 2023-12-31 | €-21.94 Million ≈ $-25.65 Million |
-141.63% |
| 2022-12-31 | €52.71 Million ≈ $61.62 Million |
-81.31% |
| 2021-12-31 | €282.00 Million ≈ $329.69 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to SANIONA AB (PUBL)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 25638700000.0% over the analyzed period, indicating profitable operations and earnings retention.
SANIONA AB (PUBL) Net Assets Breakdown (December 2025)
SANIONA AB (PUBL) net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €987.70 Million | 155.50% |
| Total Equity | €635.16 Million | 100.00% |
SANIONA AB (PUBL) Competitors by Market Cap
The table below lists competitors of SANIONA AB (PUBL) ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hamat Group Ltd
TA:HAMAT
|
$150.50 Million |
|
Kuen Chaang Uppertech
TWO:6265
|
$150.60 Million |
|
Nine Energy Service, Inc.
NYSE:NINE
|
$150.66 Million |
|
TGE Value Creative Solutions Corp
NYSE:BEBE
|
$150.75 Million |
|
Indo Borax & Chemicals Limited
NSE:INDOBORAX
|
$150.48 Million |
|
Seven Hills Realty Trust
NASDAQ:SEVN
|
$150.44 Million |
|
Go Fashion (India) Limited
NSE:GOCOLORS
|
$150.31 Million |
|
Cristales
SN:CRISTALES
|
$150.31 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SANIONA AB (PUBL)'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 231,818,000 to 635,159,000, a change of 403,341,000 (174.0%).
- Net income of 284,666,000 contributed positively to equity growth.
- New share issuances of 114,951,000 increased equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €284.67 Million | +44.82% |
| Share Issuances | €114.95 Million | +18.1% |
| Other Changes | €3.72 Million | +0.59% |
| Total Change | €- | 173.99% |
Book Value vs Market Value Analysis
This analysis compares SANIONA AB (PUBL)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.20x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €3.82 | €0.93 | x |
| 2022-12-31 | €0.71 | €0.93 | x |
| 2023-12-31 | €-0.29 | €0.93 | x |
| 2024-12-31 | €2.06 | €0.93 | x |
| 2025-12-31 | €4.60 | €0.93 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SANIONA AB (PUBL) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 44.82%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 65.53%
- • Asset Turnover: 0.64x
- • Equity Multiplier: 1.07x
- Recent ROE (44.82%) is above the historical average (-84.18%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -145.71% | -3921.53% | 0.02x | 1.56x | €-439.10 Million |
| 2022 | -401.40% | -1384.34% | 0.10x | 2.92x | €-216.84 Million |
| 2023 | 0.00% | -568.94% | 0.26x | 0.00x | €-93.62 Million |
| 2024 | 81.40% | 56.39% | 0.99x | 1.47x | €165.52 Million |
| 2025 | 44.82% | 65.53% | 0.64x | 1.07x | €221.15 Million |
Industry Comparison
This section compares SANIONA AB (PUBL)'s net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $82,275,373
- Average return on equity (ROE) among peers: -15.87%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SANIONA AB (PUBL) (30S) | €635.16 Million | -145.71% | 0.07x | $150.48 Million |
| TME PHARM.CONF.IPO EO 1- (0N6A) | $-294.00K | 0.00% | 0.00x | $10.44 Million |
| PROQR THERAPEUTICS EO-04 (0PQ) | $88.56 Million | -31.35% | 0.90x | $141.29 Million |
| TIZIANA LIFE SCIENCES LTD (0RP) | $19.57 Million | -78.67% | 0.35x | $141.34 Million |
| Theravance Biopharma Inc (0TB) | $-223.84 Million | 0.00% | 0.00x | $828.57 Million |
| I-MAB SPONS.ADS/1 -0001 (0VY) | $230.94 Million | -20.03% | 0.13x | $125.74 Million |
| PreveCeutical Medical Inc (18H) | $-3.60 Million | 0.00% | 0.00x | $3.34 Million |
| Argen-X (1AE) | $538.39 Million | -12.38% | 0.07x | $41.67 Billion |
| GH RESEARCH PLC DL-025 (1KA) | $218.97 Million | -16.25% | 0.03x | $1.22 Billion |
| WAVE LIFE SCIENCES LTD. (1U5) | $-45.09 Million | 0.00% | 0.00x | $699.56 Million |
| BIOCURE TECHNOLOGY INC. (1WH) | $-852.32K | 0.00% | 0.00x | $960.84K |
About SANIONA AB (PUBL)
Saniona AB (publ), a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom. It also develops medicines modulating ion channels. The company's product includes Tesofensine, a monoamine reuptake inhibitor that has completed Phase 3 clinical t… Read more